Development Features on the Selection of Animal Models for Teratogenic Testing

Area of Science:

• Developmental toxicology
• Comparative embryology
• Animal model systems

Background:

• Animal models are essential for teratogenic testing of new substances.
• Similar developmental processes in animals aid human safety assessments.
• Embryology advances highlight sensitivity to toxicity during development.

Purpose of the Study:

• Outline essential developmental periods in various animal models for teratogenic testing.
• Compare species' similarities, differences, advantages, and disadvantages.
• Highlight specific sensitivities for teratogenic testing across models.

Main Methods:

• Categorize animal models into invertebrate, non-mammalian vertebrate, and mammalian species.
• Detail specific examples within each category (e.g., Eisenia fetida, Xenopus laevis, Mus musculus).
• Discuss regulatory requirements and the increasing use of alternative models.

Main Results:

• Invertebrates (e.g., Eisenia fetida, C. elegans, D. melanogaster) offer rapid results and fewer ethical concerns.
• Non-mammalian vertebrates (e.g., Xenopus laevis, Danio rerio) assess later development with reduced ethical demands.
• Mammals (e.g., Mus musculus, Rattus norvegicus) are vital for complex, late-stage development but face ethical and cost limitations for screening.

Conclusions:

• Invertebrate and non-mammalian vertebrate models are valuable for high-throughput screening due to cost-effectiveness and ethical advantages.
• Improved understanding of developmental pathways enhances human translation and reduces animal use.
• Optimized animal model selection improves compound safety profiles and accelerates market entry.